NYSE · EW · Medical Devices
Edwards Lifesciences Corporatio (EW) stock analysis
- EW lost 0.4% over the past month versus 0.0% for the S&P 500, ranking 320th of 497 S&P 500 stocks.
- Over 12 months it returned +17.4%, 1.6 points ahead of the S&P 500, and trades 7.1% below its 52-week high.
- In the last 30 days 1 analyst raised earnings estimates and 1 cut; forward EPS moved +0.2% (+0.6% over 90 days).
- It sits in the Cardiovascular & structural heart segment of the Healthcare Value Chain, where the 1-month median return is −0.4%.
- The daily chart reads Trend transition · Unresolved structure (since Oct 20, 2026).
One-year price with 50- and 200-day averages
Performance vs the market
Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.
Chart structure
Read by our daily-bar structure engine from swing highs, swing lows and moving averages.
Holding since Oct 20, 2026
- Price and averages have mixed alignment
- EMA50 fell over the last ten sessions
- Intermediate and long-term directions differ
- Neither a stable trend nor a range is confirmed
79 occurrences in 10 years. The median move over the next 20 sessions was +2.5%, positive 57% of the time, against +1.3% for any day in the same period.
Analyst earnings revisions
Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.
26 analysts cover the stock
Where it sits in the supply chain
Healthcare Value Chain · Drugs & devices
Electrophysiology, stents and heart valves, where new technologies shift share as they ramp.
Also on: Medtech, Diagnostics & Care
Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps
Risk profile
Themes
- MedTech3M rank 36 / 90
Track this stock every day
Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.